Bovine malignant catarrhal fever

Lore & Background

Bovine malignant catarrhal fever is caused by gammaherpesviruses that cause unapparent infection in reservoir hosts but are usually fatal in cattle and other ungulates. In Southern Africa it is known as snotsiekte. The disease is most prevalent where reservoir and susceptible animals mix, with particular problems in Bali cattle in Indonesia, bison in the US, and pastoralist herds in Eastern and Southern Africa. Outbreaks are usually sporadic, though infection of up to 40% of a herd has been reported.

Reader's Guide

Bovine malignant catarrhal fever is a significant disease in regions where reservoir hosts and susceptible animals coexist. In Africa, wildebeest carry AlHV-1 lifelong, shedding virus in nasal secretions, especially in calves under one year old. Transmission to cattle typically follows the wildebeest calving period. In the rest of the world, sheep and goats transmit OvHV-2 to cattle and deer, particularly during lambing. The disease is also a problem in zoological collections. No commercial treatment or vaccine exists, so control relies on livestock management, such as keeping cattle away from wildebeest during calving. This practice excludes Maasai pastoralists from prime grazing land during the wet season, reducing productivity. In Eastern and Southern Africa, MCF is among the five most important problems affecting pastoralists.

Did You Know?

• The disease is known as snotsiekte in Southern Africa, from the Afrikaans.
• Père David's deer, Bali cattle, and bison are particularly susceptible, with many deer dying within 48 hours of first symptoms.
• The virus does not grow in cell cultures, complicating vaccine development.
• Sheep shed OvHV-2 more from 6–9 month old lambs than from adults.

Reservoir Hosts and the Invisible Carrier

The viruses responsible for BMCF—Alcelaphine gammaherpesvirus 1 and Ovine gammaherpesvirus 2—maintain a deceptively quiet existence in their natural reservoir species. Wildebeest harbor AlHV-1 as a lifelong, completely asymptomatic infection, passing it vertically from mother to calf and shedding it primarily through nasal secretions of calves under one year of age. Similarly, sheep and goats carry OvHV-2 without apparent illness, with viral DNA detectable across their alimentary, respiratory, and urogenital tracts. The critical transmission window in Africa aligns with the wildebeest calving season, when young calves are the most active shedders. In other regions, close contact with sheep or goats during lambing poses the greatest risk to cattle and deer. What makes this dynamic particularly insidious is that cattle, once infected, cannot transmit the disease to other cattle, meaning the reservoir species remain the sole engine of spread. No commercial vaccine or curative treatment exists, leaving only management strategies—such as separating cattle from wildebeest during the wet season—as a practical means of control.

Clinical Progression and the Inevitable Outcome

The head and eye form represents the most frequently observed clinical pattern of BMCF. Affected animals develop fever, depression, profuse ocular and nasal discharge, mucosal lesions on the muzzle and buccal cavity, and progressive lymph node swelling. Corneal opacity advances toward blindness, while inappetence and diarrhea compound the animal's decline. Neurologic manifestations—including ataxia, nystagmus, and head pressing—may emerge, and some patients exhibit extreme tactile sensitivity around the head, aggressive charging behavior, and even seizures. The disease course is relentless: once clinical signs manifest, recovery is impossible. Death typically follows within five to ten days of the first observable symptoms. Fulminant, alimentary, and cutaneous variants have also been documented, all sharing the same grim trajectory. The mortality rate among symptomatic animals stands at 90 to 100 percent. Certain species succumb with terrifying speed; Père David's deer and many other deer species can die within 48 hours of initial symptoms, while bison fall within three days. In contrast, cattle generally endure a week or more before death. Treatment remains strictly supportive, offering comfort but no cure.

Geographic Patterns and Pastoralist Impact

BMCF manifests in distinct geographic patterns tied to the distribution of its reservoir hosts. In Eastern and Southern Africa, the disease is classified among the five most critical threats to pastoralist livelihoods, alongside East coast fever, contagious bovine pleuropneumonia, foot and mouth disease, and anthrax. The practical consequence of the only available control measure—separating cattle from wildebeest during the calving period—is severe: Maasai herders in Tanzania and Kenya are effectively barred from prime grazing land during the wet season, directly reducing herd productivity. In Indonesia, Bali cattle face a particular vulnerability, while in North America, bison in feedlots have been diagnosed with BMCF even without direct sheep contact, with OvHV-2 detected in herds up to five kilometers from the nearest lambing flock, infection levels declining proportionally with distance. Zoological collections present another hotspot, where reservoir and susceptible species are routinely housed in close proximity. Outbreaks in cattle herds tend to be sporadic, though infection rates as high as 40 percent of a herd have been recorded, with the underlying reasons for this variability remaining unexplained.

Diagnostic Challenges and Laboratory Identification

Confirming BMCF in a living or recently deceased animal is complicated by the fact that its clinical signs closely mimic those of blue tongue, bovine viral diarrhea mucosal disease, and foot and mouth disease. The World Organisation for Animal Health designates histopathology as the definitive diagnostic tool, revealing the hallmark lesion of lymphocytic arteritis with blood vessel wall necrosis and the presence of large T lymphocytes intermixed with other inflammatory cells. In practice, modern laboratories increasingly rely on a combination of clinical history, symptom assessment, ELISA detection of viral antibodies in blood or tissues, and PCR amplification of viral DNA. A further complication arises because AlHV-1 and OvHV-2 are nearly indistinguishable by conventional methods and require molecular sequencing for definitive differentiation, though some researchers have identified subtle histologic differences such as the presence or absence of necrosis and patterns of lymphoid accumulation. Cross-reactive antibodies between sheep infected with OvHV-2 and cattle suffering from AlHV-1-associated disease add another layer of interpretive difficulty. The incubation period remains formally unknown, though experimental intranasal challenge with AlHV-1 produced disease in every challenged cattle between 2.5 and six weeks.